Kerry Oliver
Primary Care · Phoenix, AZNPI 1306341748
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 29.0% of the total.
Across 148 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$713
- Pfizer$422
- Novo Nordisk$286
- Lilly USA, LLC$169
- Abbott$152
- Shield Therapeutics Inc$127
- plus $589 from 17 others
What the payments were for
- Food & beverage$2,447100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $713 |
| Pfizer | 24 | $422 |
| Novo Nordisk | 19 | $286 |
| Lilly USA, LLC | 10 | $169 |
| Abbott | 8 | $152 |
| Shield Therapeutics Inc | 4 | $127 |
| AstraZeneca | 5 | $92 |
| Kaleo, Inc. | 3 | $83 |
| Bausch Health US, LLC | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Currax Pharmaceuticals LLC | 3 | $44 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Amgen | 2 | $31 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Vistapharm, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Novartis | 1 | $13 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
How this compares
$2,459 in reported general payments places this provider in the 80th percentile of 151 primary care providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 43 | $59,112 |
| TrulicityDulaglutide | 19 | $19,858 |
| Levothyroxine Sodium | 110 | $2,024 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,726 |
| SynthroidLevothyroxine Sodium | 13 | $1,367 |
| Rosuvastatin Calcium | 121 | $1,133 |
| Np ThyroidThyroid,pork | 13 | $1,004 |
| Liothyronine Sodium | 13 | $734 |
| Ezetimibe | 32 | $727 |
| Risedronate Sodium | 18 | $630 |
| Fenofibric AcidFenofibric Acid (Choline) | 11 | $579 |
| Losartan Potassium | 67 | $542 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $533 |
| Amlodipine Besylate | 93 | $503 |
| Atorvastatin Calcium | 63 | $479 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $286 | $59,11243 claims |
| Lilly USA, LLCTrulicity | $169 | $19,85819 claims |
| AbbVieSynthroid | $713 | $1,36713 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $15 | $1,00413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 151 primary care providers in Arizona.
Other primary care in Phoenix
- Trey PowrzanasPhoenix$16K
- Christine Rocks-LopezPhoenix$14K
- Elena KlimovaPhoenix$8K
- Albert VillafaniaPhoenix$8K
- Daniela HaimovPhoenix$8K
- Charity CorreaPhoenix$5K
- Cara Loveless-FaulknerPhoenix$4K
- Chelsea GreenwoodPhoenix$4K
- Kathryn SuessPhoenix$2K
- Nahla ChircoPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.